The Discounted Cash Flow (DCF) valuation of Tekla Healthcare Investors (HQH) is 47.39 USD. With the latest stock price at 15.58 USD, the upside of Tekla Healthcare Investors based on DCF is 204.2%.
Based on the latest price of 15.58 USD and our DCF valuation, Tekla Healthcare Investors (HQH) is a buy. buying HQH stocks now will result in a potential gain of 204.2%.
Range | Selected | |
WACC / Discount Rate | 7.1% - 8.3% | 7.7% |
Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
Fair Price | 41.65 - 55.21 | 47.39 |
Upside | 167.4% - 254.4% | 204.2% |